A COVID-19 vaccine candidate, tested by the American pharmaceutical giant Pfizer, and the German biotech firm BioNTech SE, is safe, well-tolerated, and can generate antibodies in people, according to a study. The research, which is published in the preprint server medRxiv and is yet to be peer-reviewed, describes the preliminary clinical data for the candidate […]
